Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving treatment strategies and the impact of centralization on outcomes in thymic epithelial tumors: A nationwide population-based study from the Netherlands.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Deformable lung models for anatomical lung resections: The introduction of simulated reality for imaging guidance.

JTCVS techniques·2026
Same author

Manual three-dimensional reconstruction of patient specific lung anatomy from CT scans.

Multimedia manual of cardiothoracic surgery : MMCTS·2026
Same author

Sustainable Employability in Cardiothoracic Surgery: A Systematic Review Identifying Job Demands and Resources.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2025
Same author

State-of-the-art artificial intelligence methods for pre-operative planning of cardiothoracic surgery and interventions: a narrative review.

Journal of thoracic disease·2025
Same author

Artificial intelligence-based pulmonary vessel segmentation: an opportunity for automated three-dimensional planning of lung segmentectomy.

Interdisciplinary cardiovascular and thoracic surgery·2025

Related Experiment Videos

[Risk-adjusted hospital mortality rates].

Sabrina Siregar1, Michel I M Versteegh, Lex A van Herwerden

  • 1Universitair Medisch Centrum Utrecht, afd. Cardio-Thoracale Chirurgie, Utrecht, the Netherlands. s.siregar@umcutrecht.nl

Nederlands Tijdschrift Voor Geneeskunde
|December 22, 2011
PubMed
Summary

Healthcare providers should establish registries to accurately compare quality of care using risk-adjusted mortality rates. This ensures fair benchmarking and improves patient outcomes through data-driven feedback.

Related Experiment Videos

Area of Science:

  • Healthcare Quality Improvement
  • Medical Informatics
  • Public Health

Background:

  • Inaccurate risk-adjustment of mortality rates leads to unfair comparisons of hospital quality.
  • Need for standardized methods to ensure reliable outcome assessment.

Purpose of the Study:

  • To advocate for healthcare providers to maintain their own registries for risk-adjusted outcome monitoring.
  • To highlight the importance of case-mix adjustment in quality benchmarking.

Main Methods:

  • Utilizing a national registry (Netherlands Association for Cardio-Thoracic Surgery) as an example.
  • Collecting data on 18 risk factors and in-hospital mortality for adult cardiac surgery patients.
  • Inclusion of over 60,000 interventions since 2007.

Main Results:

  • The registry enables monitoring and benchmarking of risk-adjusted outcomes.
  • Frequent feedback on risk-adjusted mortality rates aids participating hospitals in quality control.
  • Demonstrates a model for improving transparency and accuracy in healthcare outcome reporting.

Conclusions:

  • Healthcare providers should implement registries for accurate risk-adjusted outcome measurement.
  • Registries serve as crucial quality instruments, offering deeper insights beyond simplified published results.
  • Adoption of such registries can lead to significant improvements in the quality of care.